GT Biopharma Inc (GTBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -21,460 | -23,489 | -501 | -5,171 | -3,700 |
| Depreciation Amortization | 2,496 | 2,781 | 691 | 43 | 307 |
| Accounts receivable | N/A | N/A | -40 | N/A | N/A |
| Other Working Capital | 905 | -221 | 477 | 538 | 604 |
| Other Operating Activity | 13,402 | 19,180 | -1,069 | 3,603 | 1,826 |
| Operating Cash Flow | $-4,657 | $-1,749 | $-442 | $-987 | $-963 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1 | -6 | N/A | -2 | N/A |
| Investing Cash Flow | $-1 | $-6 | $N/A | $-2 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 3,850 | 2,589 | 433 | 930 | 977 |
| Debt Repayment | N/A | -6 | -8 | N/A | N/A |
| Common Stock Issued | N/A | N/A | N/A | N/A | 24 |
| Financing Cash Flow | $3,850 | $2,583 | $425 | $930 | $1,001 |
| Beginning Cash Position | 855 | 43 | 123 | 92 | 54 |
| End Cash Position | 47 | 855 | 43 | 123 | 92 |
| Net Cash Flow | $-808 | $812 | $-80 | $31 | $38 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,657 | -1,749 | -442 | -987 | -963 |
| Capital Expenditure | -1 | -6 | N/A | -2 | N/A |
| Free Cash Flow | -4,658 | -1,755 | -442 | -989 | -963 |